Caris Life Sciences, Inc. (CAI)
25.63
-0.75
(-2.84%)
USD |
NASDAQ |
Aug 28, 16:00
25.63
0.00 (0.00%)
After-Hours: 20:00
Caris Life Sciences Free Cash Flow : 116.25M for June 30, 2026
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2026 | 116.25M |
| March 31, 2026 | 115.75M |
| December 31, 2025 | 59.18M |
| September 30, 2025 | -14.01M |
| Date | Value |
|---|---|
| June 30, 2025 | -140.59M |
| March 31, 2025 | -212.01M |
| December 31, 2024 | -253.64M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| CareDx, Inc. | 84.03M |
| Myriad Genetics, Inc. | -14.20M |
| BioRestorative Therapies, Inc. | -11.90M |
| Natera, Inc. | 51.20M |
| Exagen, Inc. | -7.588M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 28.48M |
| Cash from Investing (Quarterly) | -122.19M |
| Cash from Financing (Quarterly) | -36.90M |
| Free Cash Flow Per Share (Quarterly) | 0.0226 |
| Free Cash Flow to Equity (Quarterly) | -15.04M |
| Free Cash Flow to Firm (Quarterly) | 15.98M |
| Free Cash Flow Yield | 1.61% |